ImpediMed Limited

—As of Sun 8 Nov 2026, 12:00 UTC
ASX:IPDHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (46.60%)
Div yield —
ROE (162.35%)
Medical Devices
Beta (5Y) 1.00
PE TTM —
TSR TTM (92.11%)
Mkt cap A$10.99M
ROIC (42.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0039
29.46%
(1.63%)
Hold 4|11|1|2|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
16.98%
10.46%
13.47%
13.22%
Revenue$M
0.873
0.879
0.869
0.859
2.79%
6.35%
6.30%
1.36%
Peers (US$7.546M)
Cap (US$)
PE
8.503M
—
7.404M
—
Capital
TTM
5Y
10Y
Leveragex
1.322
0.257
0.234
EBIT/Intx
0.167
0.480
0.378
Own earn%
(132.79)
9.57
12.08
Sh yield%
31.32
22.69
22.52
Owners
Insiders/Inst%
5.15
32.32
Short interest%
5.81
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
19–33
$1 testx
—
Incr. ROIC%
9